3 completed, 3 withdrawn, 1 active not recruiting, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 3, Withdrawn 3, Active not recruiting 1, Unknown 1 |
Follow Nerve Sheath Neoplasms: new trials by email Literature Review of Nerve Sheath Neoplasms trials Research Report on Nerve Sheath Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography Indocyanine green - Neuroma, Neuroma Amputation | Phase 4 | Withdrawn | Northwestern University | 2024-12-28 | 2025-01-01 | |
| The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome N-Acetyl cysteine, Wrist Splint - Carpal Tunnel Syndrome, Hand Injuries and Disorders | Phase 4 | Unknown | Emily Krauss | 240 | 2022-04-01 | 2024-08-23 |
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| Dexmedetomidine and Propofol for Pediatric MRI Sedation propofol, Dexmedetomidine, Glycopyrrolate - Headache, Tumor | Phase 4 | Completed | Medical College of Wisconsin | 40 | 2018-03-04 | 2020-02-21 |
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Gentamicin - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-04-01 | 2020-09-11 | |
| Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Gentamicins - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-01-01 | 2020-09-11 | |
| Pathophysiology of Post Amputation Pain Bupivacaine, Placebo - Amputation Stumps, Neuroma | Phase 4 | Completed | Shirley Ryan AbilityLab | 16 | 2012-05-01 | 2015-07-21 |
| NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate methylphenidate - Neurofibromatosis Type 1 | Phase 4 | Completed | Hospices Civils de Lyon | 80 | 2004-01-01 | 2011-01-27 |
Neuroma (3) · Neurofibromatosis 1 (2) · Neuroma, Acoustic (2) · Abdominal Neoplasms (1) · Astrocytoma (1) · Carpal Tunnel Syndrome (1) · Disease (1) · Epilepsy (1) · Ganglioglioma (1) · Ganglioneuroma (1) · Glioblastoma (1) · Glioma (1) · Hand Injuries (1) · Headache (1) · Histiocytosis, Langerhans-Cell (1)
Neoplasms by Histologic Type (8) · Neoplasms, Nerve Tissue (8) · Neoplasms (7) · Nervous System Diseases (6) · Neoplasms by Site (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplastic Syndromes, Hereditary (3) · Nervous System Neoplasms (3) · Neurocutaneous Syndromes (3) · Neurodegenerative Diseases (3) · Neuroectodermal Tumors (3)
Gentamicins (2) · Acetylcysteine (1) · Bupivacaine (1) · Dexmedetomidine (1) · Dry Needling (1) · Glycopyrrolate (1) · Indocyanine Green (1) · Lidocaine (1) · Methylphenidate (1) · Nitrous Oxide (1) · Propofol (1) · Sevoflurane (1) · dabrafenib (1) · trametinib (1)
Lund University (2) · Emily Krauss (1) · Hospices Civils de Lyon (1) · Medical College of Wisconsin (1) · Northwestern University (1) · Novartis Pharmaceuticals (1) · Shirley Ryan AbilityLab (1)
United States (4) · Sweden (3) · Canada (2) · France (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1)
Gregory A Dumanian, MD (1) · Michael Bezuhly, MD (1) · Norman Harden, M.D. (1) · Susan P Taylor, MD, MPH (1)
PMID 17917842, PMID 19574236, PMID 19645909, PMID 22027076, PMID 18607963, PMID 25205361
2023 (1)